Helius Medical Technologies Inc Class A (HSDT) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $2.11
• Market Cap: $114.58M
• EPS: $-829.83
• 52-Week High: $397.80
• 52-Week Low: $1.74

About Helius Medical Technologies Inc Class A

Helius Medical Technologies, Inc. (HSDT) is a pioneering neurotechnology company focused on developing and commercializing non-invasive therapies designed to alleviate symptoms related to neurological disorders and trauma. The company leverages cutting-edge technologies to meet significant unmet medical needs in the neurorehabilitation market, demonstrating a strong commitment to improving patient outcomes and enhancing quality of life for individuals affected by these conditions. Based in Ne...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Helius Medical Technologies Inc Class A and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HSDT pay dividends?

Helius Medical Technologies Inc Class A (HSDT) does not currently pay a regular dividend.

What is HSDT's market cap?

Helius Medical Technologies Inc Class A (HSDT) has a market capitalization of $114.58M with a current stock price of $2.11.